Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Meyer

Showing results (21-30 of 94) with videos related to

Pageof 10
Sort By:
Blood Purification|May 25, 2022
Improving Solute Clearances by HemodialysisSeolhyun Lee, Tammy L Sirich, Timothy W Meyer
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Searching for uremic toxinsMirela Dobre, Timothy W Meyer, Thomas H Hostetter
Journal of the American Society of Nephrology : JASN|June 23, 2000
Contribution of angiotensin II to late renal injury after acute ischemiaMaria Enrica Pagtalunan, Jean L Olson, Timothy W Meyer
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2010
Anemia therapy in ESRD: time to move onVaughn W Folkert, Timothy W Meyer, Thomas H Hostetter
Kidney International|February 19, 2002
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiencyFiona E Mackie, Timothy W Meyer, Duncan J Campbell
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 27, 2009
p-Cresol sulfate: further understanding of its cardiovascular disease potential in CKDJames F Winchester, Thomas H Hostetter, Timothy W Meyer
Seminars in Dialysis|September 21, 2011
Dialysis cannot be dosedTimothy W Meyer, Tammy L Sirich, Thomas H Hostetter
Current Opinion in Nephrology and Hypertension|October 23, 2008
New insights into uremic toxicityAmanda C Raff, Timothy W Meyer, Thomas H Hostetter
Toxins|June 6, 2018
Uremic Toxin Clearance and Cardiovascular ToxicitiesRobert D Mair, Tammy L Sirich, Timothy W Meyer
The New England Journal of Medicine|January 4, 2008
UremiaFrancis J Haddy, Timothy W Meyer, Thomas H Hostetter
Pageof 10

Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Blood Purification|May 25, 2022
Improving Solute Clearances by HemodialysisSeolhyun Lee, Tammy L Sirich, Timothy W Meyer
Clinical Journal of the American Society of Nephrology : CJASN|October 2, 2012
Searching for uremic toxinsMirela Dobre, Timothy W Meyer, Thomas H Hostetter
Journal of the American Society of Nephrology : JASN|June 23, 2000
Contribution of angiotensin II to late renal injury after acute ischemiaMaria Enrica Pagtalunan, Jean L Olson, Timothy W Meyer
Clinical Journal of the American Society of Nephrology : CJASN|June 12, 2010
Anemia therapy in ESRD: time to move onVaughn W Folkert, Timothy W Meyer, Thomas H Hostetter
Kidney International|February 19, 2002
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiencyFiona E Mackie, Timothy W Meyer, Duncan J Campbell
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 27, 2009
p-Cresol sulfate: further understanding of its cardiovascular disease potential in CKDJames F Winchester, Thomas H Hostetter, Timothy W Meyer
Seminars in Dialysis|September 21, 2011
Dialysis cannot be dosedTimothy W Meyer, Tammy L Sirich, Thomas H Hostetter
Current Opinion in Nephrology and Hypertension|October 23, 2008
New insights into uremic toxicityAmanda C Raff, Timothy W Meyer, Thomas H Hostetter
Toxins|June 6, 2018
Uremic Toxin Clearance and Cardiovascular ToxicitiesRobert D Mair, Tammy L Sirich, Timothy W Meyer
The New England Journal of Medicine|January 4, 2008
UremiaFrancis J Haddy, Timothy W Meyer, Thomas H Hostetter
Pageof 10